Gastrointestinal malignancy
Conditions
Interventions
Experimental Group:Operation platform for comprehensive processing of gastrointestinal tissue specimens
Control Group:Traditional specimen processing
Sponsors
Beijing Friendship Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with malignant tumors of stomach and intestine in clinical surgery and need surgical intervention treatment; 2. Unlimited age and gender, physical score ECOG<=2, ASA score <=2, resistant to surgery, normal liver, kidney and bone marrow function; 3. Ability to abide by the plan during the study and sign an informed consent; 4. The patient is willing to follow up and cooperate with the full-time staff to make relevant records.
Exclusion criteria
Exclusion criteria: 1. Patients with severe cardiopulmonary disease and intolerance to surgery; 2. Patients who are reluctant to bear the risk of surgery and fail to sign the informed consent for surgery; 3. Uncontrollable medical diseases (including unstable angina pectoris, myocardial infarction, cerebrovascular accident within 6 months); 4. Cannot receive general anesthesia or surgical treatment due to other organs in the whole body; 5. Have a history of uncontrolled epilepsy, central nervous system diseases or mental disorders; 6. Women of childbearing age during pregnancy or lactation; 7. Preoperative laboratory examinations clearly identify persons with infectious diseases such as AIDS, syphilis, and hepatitis B; 8. Participate in other clinical trials at the same time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of lymph nodes detected; | — |
Countries
China
Contacts
Public ContactZhang Jun
Beijing Friendship Hospital
Outcome results
None listed